Recombinant Tissue Factor Pathway Inhibitor in Severe Community-acquired Pneumonia: A Randomized TrialRichard G. Wunderink, Steven M. Opal, Antonio Artigas et al.|American Journal of Respiratory and Critical Care Medicine|2011Cited by 128